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ABSTRACT
Background: Currently, there is a great debate about the 
pathophysiology of acute myocardial infarction and tissue 
composition and morphology of lesions responsible for 
ischemic events. However, few studies have investigated the 
applicability of tissue characterization using iMAP™ technol-
ogy in these patients. We evaluated patients with ST-segment 
elevation myocardial infarction after thrombolytic therapy with 
grayscale intravascular ultrasound and iMAP™ technology to 
describe the tissue composition of the culprit lesions. Meth-
ods: Twenty-five ST-segment elevation myocardial infarction 
patients with successful reperfusion had the three major epi-
cardial coronary arteries evaluated by grayscale intravascular 
ultrasound and iMAP™ technology. Results: Mean age was 51 
± 11.5 years with a prevalence of males (72%). The artery 
most often involved was the right coronary artery (48%). 
Intravascular ultrasound showed that the culprit lesions were 
long (mean extension 31.0 ± 17.2 mm) with a high percent 
of plaque volume (58.5 ± 5.1%). At the point of highest 
obstruction (minimal luminal area), the plaque burden was 
82.5 ± 7.5%. Furthermore, the mean remodeling index was 
1.4 ± 1.0, indicating positive remodeling. iMAP™ analysis of 
the lesion and minimal luminal area showed a prevalence of 
fibrotic and necrotic components when compared to other 
components. Conclusions: In ST-segment elevation myocardial 
infarction patients, the culprit lesion showed a prevalence of 
positive arterial remodeling and the necrotic core component 
in the composition of the culprit plaque corroborating in vivo 
the main pathophysiology of acute atherosclerotic disease.
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RESUMO
Caracterização Morfológica e Tecidual de Lesões 
Culpadas em Pacientes com Infarto Agudo do 
Miocárdio com Supradesnivelamento do Segmento 
ST Após Uso de Fibrinolítico. Análise com Ultrassom 
Intracoronário e Tecnologia iMAP®
Introdução: Atualmente, existe grande debate acerca da fisiopa-
tologia do infarto agudo do miocárdio e da composição tecidual 
e morfológica das lesões responsáveis por eventos isquêmicos. 
Entretanto, poucos estudos investigaram a aplicabilidade da 
tecnologia iMAP® na caracterização tecidual desses pacientes. 
Avaliamos pacientes com infarto agudo do miocárdio com su-
pradesnivelamento do segmento ST pós-fibrinolítico com ultrassom 
intravascular em escala de cinzas e com a tecnologia iMAP®, a 
fim de descrever a composição tecidual das lesões culpadas pelo 
infarto agudo do miocárdio. Métodos: Foram avaliadas três artérias 
coronárias epicárdicas com ultrassom intravascular em escala de 
cinzas e com a tecnologia iMAP® de 25 pacientes com infarto 
agudo do miocárdio com supradesnivelamento do segmento ST 
pós-trombólise, com critérios de reperfusão. Resultados: A mé-
dia de idade foi de 51 ± 11,5 anos, com predomínio do sexo 
masculino (72%). A artéria mais frequentemente envolvida foi a 
coronária direita (48%). O ultrassom intravascular mostrou que 
as lesões culpadas eram longas (extensão de 31,0 ± 17,2 mm) 
e com elevado porcentual de volume de placa (58,5 ± 5,1%). 
No ponto de maior obstrução, ou seja, na área luminal mínima, 
a carga de placa foi de 82,5 ± 7,5%. Além disso, o índice de 
remodelamento médio foi de 1,4 ± 1,0, denotando remodelamento 
positivo. As análises pelo iMAP®, tanto da lesão, quanto da área 
luminal mínima, mostraram predomínio em termos porcentuais 
de componentes fibrótico e necrótico, quando comparados aos 
demais. Conclusões: As lesões ateroscleróticas culpadas pelo 
infarto agudo do miocárdio com supradesnivelamento do seg-
mento ST apresentaram predomínio de remodelamento arterial 
positivo e do componente necrótico na composição da placa 
culpada, o que corrobora, in vivo, a principal fisiopatologia da 
doença aterosclerótica aguda.
DESCRITORES: Infarto do miocárdio. Placa aterosclerótica. 
Terapia trombolítica. Ultrassonografia.
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A cute myocardial infarction (AMI) is a clinical entity normally resulting from partial (non-ST-segment elevation MI – NSTEMI) or total throm-
botic obstruction (ST-segment elevation MI – STEMI) 
of a epicardial coronary artery.1 Pathological studies 
have shown that the triggering event in thrombus for-
mation and subsequent vessel occlusion results from 
the rupture of a atherosclerotic fibrous cap in 60% of 
cases, from plaque erosion in 30 to 35%, and from a 
thrombus formation superimposed on calcium nodules 
in 5 to 10%.2,3
However, much is still debated about the compo-
sition of atherosclerotic plaques that develop from a 
condition considered stable to a situation of instability, 
with consequent outbreak of thrombotic events and 
acute coronary ischemia. In this situation, the intra-
vascular ultrasound (IVUS) is an important tool in the 
identification and characterization of the morphology 
of atherosclerotic plaques related to AMI, although it is 
not possible to identify plaque erosion due to limitations 
in spatial resolution, a problem that can be overcome 
using optical coherence tomography (OCT).4,5 The IVUS 
identifies plaque and calcium nodule rupture with high 
sensitivity and specificity. Additionally, several findings 
at IVUS are characteristic of unstable plaques, such as 
extensive positive remodeling6 and the presence of small 
amounts of calcium with localized and scattered distri-
bution (spotty calcification).7,8 Recently, the application 
of tissue characterization with the iMAP™ technology 
(Boston Scientific, Santa Clara, United States) made 
further progress in the identification of atherosclerotic 
plaque composition, identifying and quantifying the 
lipidic and necrotic contents, which are directly related 
to lesion instability.9 Unlike the VH-IVUS® technology 
(Volcano Corporation, San Diego, United States), there 
have been few clinical studies assessing the accuracy 
of iMAP™ in the characterization of atherosclerotic 
plaques involved in STEMI. Even scarcer are the studies 
of patients submitted to thrombolytic therapy, in whom 
IVUS can be performed in vessels without any type 
of previous intervention (pre-dilation and/or thrombus 
aspiration).
The present study aimed to describe the quantita-
tive, morphological tissue findings and using IVUS with 
greyscale analysis and iMAP™ technology of culprit le-
sions in STEMI patients treated with fibrinolytic therapy.
METHODS
Patients and study design
From September 2011 to May 2012, 25 patients 
with clinical and electrocardiographic diagnosis of STEMI 
treated with fibrinolytic therapy were prospectively 
included in the study iWonder (Imaging WhOle vessel 
coroNary tree with intravascular ultrasounD and iMap 
in patiEnts with acute myocaRdial infarction). This study 
included 100 patients with NSTEMI or STEMI, whether 
or not treated with fibrinolytic therapy, and analyzed, 
through IVUS, three epicardial coronary arteries, in 
grayscale and iMAP™, regarding the phenotypic and 
tissue characteristics of culprit and non-culprit lesions.10 
The project was conducted in the Hemodynamics and 
Interventional Cardiology Division of the Hospital São 
Paulo, Escola Paulista de Medicina, Universidade Federal 
de São Paulo, São Paulo, Brazil, having been previously 
approved by the Research Ethics Committee of the insti-
tution (project 0889/11, August 5, 2011) and registered 
in ClinicalTrials.org under number NCT01437553. All 
patients or their legal guardians were informed about 
the objectives and risks of study-related procedures, 
and signed an informed consent form prior to the 
diagnostic procedure.
As part of the present subanalysis, the inclusion 
criteria were age <  75 years; clinical-electrocardio-
graphic diagnosis of STEMI with prior fibrinolytic 
therapy, with time of evolution <  30 days; identifi-
cation, through coronary angiography, of the culprit 
lesion responsible for the clinical picture; and IVUS 
assessment availability. Exclusion criteria were: STEMI 
and target-vessel with Thrombolysis in Myocardial 
Infarction (TIMI) coronary flow equal to 0; previous 
percutaneous coronary intervention (PCI) or coronary 
artery bypass graft surgery (CABG); hemodynamic 
instability; Killip class III/IV; severe renal dysfunction 
(serum creatinine > 2.0 mg/dL and/or creatinine clear-
ance ≤ 30 mL/minute); coronary anatomy unsuitable 
for IVUS performance; critical coronary obstruction 
preventing the passage of the IVUS catheter; total 
occlusion of any of three epicardial coronary arter-
ies; stenosis >  50% in the left main coronary artery 
with indication for surgical revascularization; patient 
and/or legal guardian unable to or unwilling to sign 
the informed consent. Collection of peripheral blood 
samples for complete blood count, urea, creatinine, 
glucose, total cholesterol and fractions, ultrasensitive 
C-reactive protein (us-CRP), and glycated hemoglobin 
(HbA1c) was performed.
Intravascular ultrasound procedure
The IVUS of epicardial coronary arteries was per-
formed immediately after the diagnostic procedure, 
under patient’s full heparinization (100  U/kg of un-
fractionated heparin, aiming at activated clotting time 
[ACT] between 250 and 350 seconds) and administra-
tion of an intracoronary vasodilator (100-200  μm of 
nitroglycerin). Initially, an IVUS study was performed in 
the artery related to the clinical event (culprit vessel), 
followed by angioplasty, when necessary. Subsequently, 
the other two coronary arteries unrelated to the clinical 
event (non-culprit vessels) were analyzed with IVUS. A 
40-MHz IVUS catheter (Atlantis® SR Pro; Boston Sci-
entific, Santa Clara, United States), was used with the 
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gray scale analysis and morphological characterization 
by using the iMAP-IVUS® modality (Boston Scientific, 
Santa Clara, United States). Automatic pullback move-
ments of the ultrasound catheter were performed at a 
speed of 0.5  mm/s, starting at a 10-mm distal point 
from the culprit lesion, toward the arterial ostium. For 
non-culprit arteries, the same routine was performed 
for analysis of plaques unrelated to the event.
Intravascular ultrasound image analysis
All angiography and IVUS images were stored in 
digital media and copied to an external hard drive for 
offline analysis at the Intravascular Image Laboratory 
of the Cardiovascular Research Foundation (New York, 
United States).
The IVUS analysis was performed in three sequen-
tial steps:
1. Quantitative analysis: quantitative volumetric 
analysis was performed according to current guide-
lines.11,12 This phase of the offline IVUS analysis 
consisted in the definition of the segment to be 
analyzed in each pullback, including at least 10 mm 
of extension, distal to the respective vessel ostium. 
Subsequently, using the Qivus 2.1® software (Medis 
Medical Imaging Systems, Leiden, the Netherlands) 
the automatic contours of the vessel and lumen were 
obtained at every 1 mm within the defined segment. 
Then, using Simpson’s method, the volumes of the 
lumen, vessel, and plaque (vessel minus lumen) were 
computed. The plaque burden was calculated as the 
ratio of the cross-sectional area of the plaque by the 
cross-sectional area of the vessel, multiplied by 100. 
The minimal luminal area (MLA) was defined as the 
smallest cross-sectional area of the lumen within the 
lesion. The stenosis area was calculated as the cross-
sectional area of the lumen at the MLA divided by 
the cross-sectional area of the vessel in the reference 
segment, multiplied by 100. The cross-sectional area 
of the vessel in the reference segment was defined 
as the mean proximal and distal cross-sectional area 
of the vessel, at the point where the vessel had an 
aspect closest to normal, with the largest lumen 
and lowest plaque burden. When one of the two 
reference segments (proximal or distal) could not be 
measured, the calculation was based on only one of 
them. If none of the two segments could be measured, 
variables depending on reference measures were not 
calculated. The remodeling index was calculated as 
the cross-sectional area of the vessel at the MLA 
point divided by the cross sectional area of reference.
2. Qualitative analysis: plaque rupture was defined 
as an intraplaque cavity in communication with the 
lumen, in the presence of the fibrous-cap residues or 
fragments.13 The plaque was considered as hypoechoic 
when it was predominantly (>  75%) less bright when 
compared with the adventitia, and it was considered 
as hyperechoic when it was brighter (> 75%) than the 
adventitia. Calcium nodules were defined as a dense, 
eruptive, irregular surface mass, incontact with and/or 
near the lumen.14
3. Tissue characterization by iMAP: IMAP-IVUS® 
is a type of image that uses radio-frequency spectral 
analysis to obtain an algorithm to classify the athero-
sclerotic plaque into four components: fibrotic, lipidic, 
necrotic, and calcified. The development of this algorithm 
was based on ex vivo15 histological analyses, and each 
component was assigned a color: green for the fibrotic 
component, yellow for the lipidic component, red for 
the necrotic component, and white for the calcified 
component (Figure 1).
Categorical variables were expressed as absolute 
and percentage frequencies, and continuous variables 
were expressed as means ± standard deviations.
RESULTS
The mean age of patients was 51 ± 11.5 years, 
with a predominance of male patients (72%). The time 
between the index event and performance of the IVUS 
procedure was 7.2 ± 2.1 days. Among the risk factors 
for coronary artery disease (CAD), a high prevalence 
of diabetes (40%), hypertension (60%), and smoking 
(64%) was observed. Moreover, at admission, there 
were a low proportion of patients using acetylsalicylic 
acid (ASA), as none had had a previous ischemic event. 
The other clinical and angiographic characteristics are 
summarized in Table 1.
In the analysis of the culprit lesion by IVUS with 
gray scale (Table 2), long lesions (extension of 31.0 ± 
17.2 mm) with high plaque volume (58.5 ± 5.1%) were 
Figure 1 – Intravascular ultrasound cross-sectional image with iMAP™ 
technology, depicting a large amount of necrotic (red) and fibrotic 
(green) component in addition to the lipid core (blue).
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observed. At the point of maximum obstruction (MLA), 
the lumen was 2.0 ± 1.0 mm2, while the measured 
plaque burden was 82.5 ± 7.5%. Consistent with the 
profile of patients studied, the mean rate of remodeling 
was >  1.05 (1.3 ± 1.0).
The lesion tissue analysis by iMAP™ showed a 
predominance, in percentage terms, of fibrotic and 
necrotic components, when compared to the others, 
TABLE 1  
Baseline clinical characteristics, laboratory tests,  
and drug therapy.
Variables n = 25
Age, years 51.0 ± 11.5
Male gender, n (%) 18 (72)
Body mass index, kg/m2 26.5 ± 5.7
Diabetes mellitus, n (%) 10 (40)
Hypertension, n (%) 15 (60)
Smoking, n (%) 16 (64)
Dyslipidemia, n (%) 9 (36)
Laboratory tests on admission
Total cholesterol, mg/dL 164.0 ± 70.5
HDL cholesterol, mg/dL 35.0 ± 17.3
LDL cholesterol, mg/dL 113.0 ± 42.6
Triglycerides, mg/dL 109.0 ± 59.1
Creatinine clearance, mL/min 92.0 ± 45.2
us-CRP, mg/L 5.5 ± 7.0
Fasting glucose, mg/dL 116.0 ± 62.1
Glycated hemoglobin,% 6.2 ± 2.7
Culprit artery n (%)
Left anterior descending artery 10 (40)
Left circumflex artery 3 (12)
Right coronary artery 12 (48)
Medications at admission, n (%)
ASA 4 (16)
Thienopyridines 0
ACEI/ARB 13 (52)
Statins 6 (24)
Beta-blockers 8 (32)
Medications at discharge, n (%)
ASA 25 (100)
Thienopyridines 25 (100)
ACEI/ARB 20 (80)
Statins 25 (100)
Betablockers 9 (36)
HDL: high-density lipoprotein; LDL: low-density lipoprotein; us-CRP: ultrasensitive 
C-reactive protein; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin 
II receptor blockers.
TABLE 2 
Data from intravascular ultrasound in gray scale and 
of tissue composition with iMAP™.
Analysis through grayscale of culprit lesion n = 25
Vessel area in the distal reference MLA, mm2 8.9 ± 3.3
Lumen area in the distal reference MLA, mm2 6.0 ± 2.1
Plaque area in the distal reference MLA, mm2 3.2 ± 1.4
Vessel area in the proximal reference MLA, mm2 14.8 ± 4.6
Lumen area in the proximal reference MLA, mm2 9.6 ± 2.7
Plaque area in the proximal reference MLA, mm2 5.4 ± 2.1
Lesion extension, mm 31.0 ± 17.2
Vessel volume, mm3 427.4 ± 302.8
Lumen volume, mm3 175.3 ± 123.9
Plaque volume, mm3 257.7 ± 184.5
Percentage of plaque volume, % 58.5 ± 5.1
Mean vessel area, mm3/mm 14.3 ± 2.9
Mean lumen area, mm3/mm 5.6 ± 1.3
Mean plaque area, mm3/mm 8.9 ± 1.9
Gray scale analysis of lesion MLA
Vessel area in MLA, mm2 12.9 ± 3.2
Lumen area in MLA, mm2 2.0 ± 1.0
Plaque area in MLA, mm2 10.5 ± 3.1
Plaque burden, % 82.5 ± 7.5
Remodelingindex 1.4 ± 1.0
Tissue analysis of the lesion through iMAP™
Necrotic component volume, mm3 60.0 ± 65.6
Calcified-component volume, mm3 6.1 ± 8.3
Lipidic-component volume, mm3 17.7 ± 16.2
Fibrotic-component volume, mm3 152.4 ± 112.8
Necrotic-component/calcified-component ratio 10.6 ± 13.9
Percentage of the necrotic-component volume, % 23.4 ± 9.2
Percentage of the calcified-component volume, % 2.2 ± 1.8
Percentage of the lipidic-component volume, % 7.1 ± 1.9
Percentage of the fibrotic-component volume, % 65.6 ± 10.4
Tissue analysis in the MLA through iMAP™
Percentage of the necrotic-component volume, % 23.6 ± 14.8
Percentage of the calcified-component volume, % 1.6 ± 1.7
Percentage of the lipidic-component volume, % 6.4 ± 2.6
Percentage of the fibrotic-component volume, % 63.4 ± 18.1
MLA: minimal luminal area.
demonstrating greater vulnerability and instability of 
these lesions. This finding was similar to that observed 
at the point of maximum obstruction (MLA), also with 
a predominance of fibrotic and necrotic components.
Finally, the IVUS morphological analysis showed 
that the triggering event for thrombosis was coronary 
plaque rupture in 36% of cases (9/25), while calcium 
nodules were observed in only 4% of patients (1/25).
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DISCUSSION
The present study evaluated 25 patients with STEMI 
undergoing fibrinolytic therapy referred for coronary an-
giography and submitted to IVUS of all three epicardial 
coronary arteries. The main findings were: (1) culprit 
lesions showed findings consistent with a vulnerable 
plaque, such as large necrotic core (> 20%) and reduced 
calcified content; (2) plaque rupture was the underlying 
event for coronary thrombosis in 36% of cases; and 
(3) positive arterial remodeling was present in almost 
all the lesions. The present study provides, for the first 
time in literature, the description of the morphological 
characteristics of the plaque responsible for STEMI in 
patients after the use of fibrinolytic therapy using the 
iMAP™ tissue characterization technology. A potential 
advantage of this analysis when compared to previous 
studies lies in the fact that the IVUS analysis was per-
formed after successful fibrinolytic therapy, minimizing 
the risk of thrombus interference in image interpretation.
Recent pathological studies have described the 
evolution stages of the atherosclerotic plaque, from the 
stable, incipient, and benign state, to more advanced 
stages of instability, leading to acute coronary events.2,16 
In the early stages of intimal thickening and intimal 
xanthoma, the atherosclerotic plaque is constituted 
mainly of focal accumulation of smooth muscle cells 
with extracellular matrix rich in proteoglycans, without 
signs of inflammation. From this stage onwards, athero-
sclerosis progression occurs with marked inflammatory 
component, represented mainly by macrophage infiltrates 
in the lipid core, and a decrease in proteoglycan and 
collagen in the fibrous cap. In the last phase of the 
natural course of atherosclerosis, this evolution process 
results in the formation of the so-called vulnerable plaque, 
represented by thin-cap fibroatheroma (TCFA), whose 
diagnostic findings are a large necrotic core (usually 
≥  25% of plaque area)17 surrounded by a thin fibrous 
cap (≤  65 μm) and richly infiltrated by macrophages 
with reduced amount of smooth muscle cells.16,18
One of the most often studied findings associated 
with plaque vulnerability is arterial remodeling. Initially 
described by Glagov et al.19 in 1987, the positive arte-
rial remodeling has been observed in atherosclerotic 
plaques responsible for acute coronary events,6,20,21 and 
is associated with the increase in CK-MB after PCI,22 
no-reflow phenomena during primary PCI,23 recurrent 
ischemia after PCI, 24 major cardiovascular events in 
patients with unstable angina undergoing any form 
of revascularization,25 and intimal hyperplasia after 
PCI with bare-metal26 and drug-eluting stents.27 In the 
present study, the mean arterial-remodeling index was 
1.4 ± 1.0, greater than 1.05, thus characterizing the 
predominance of positive arterial remodeling and cor-
roborating the aforementioned literature.
In addition to arterial remodeling, other data from 
the quantitative analysis of the IVUS in grayscale are 
noteworthy. One is the quantification of the plaque 
burden, of the atheroma that has been previously shown 
to be directly associated with distal embolization.28 Fur-
thermore, in the VH-IVUS in Vulnerable Atherosclerosis 
(VIVA) study,29 in which 170 patients with stable angina 
or acute coronary syndrome with troponin elevation 
were evaluated through IVUS of three vessels, one of 
the predictors of major adverse cardiovascular event 
during a mean follow-up of 625 days was the presence 
of plaque burden >  70%. Similarly, in the PROSPECT 
study,30 which assessed 697 patients with acute coronary 
syndrome submitted to IVUS of the three arteries, one of 
the most significant predictors of major cardiovascular 
adverse event associated with non-culprit lesions during 
3  years of follow-up was plaque burden >  70% (the 
other variables were the presence of TCFA and MLA 
≤  4.0  mm2). In the present analysis, involving only 
patients with STEMI, the plaque burden found in the 
culprit lesion was 82.5 ± 7.5%. A recent subanalysis 
of the PROSPECT study31 demonstrated that diabetic 
patients had even more significant findings related to 
plaque burden when compared to those without diabetes 
(56.8 vs. 55.0%; p =  0.0006). In the present study, in 
an exploratory comparison, a similar numerical trend 
was observed, with the diabetic population showing 
higher plaque burden (84.4 ± 9.0%) when compared 
to non-diabetic patients (81.5 ± 6.4%), but without 
reaching statistical significance (p  =  0.77).
In relation to the event triggering the thrombosis 
and subsequent coronary-artery occlusion, it is well 
established in the literature that plaque rupture is 
responsible for most cases (60%).3,16 In a recent study 
using OCT and comparing 80 patients with asymptomatic 
CAD and NSTEMI, Shimamura et al. demonstrated that 
symptomatic plaque rupture, i.e., associated with acute 
ischemic events, showed a higher number of plaques 
rich in lipids and thrombus, as well as lower MLA of 
the lesion and MLA at the peak of rupture.32 Of the 25 
culprit lesions analyzed in this study, plaque rupture was 
identified in 9 (36%) (Figure 2). This percentage, lower 
than that usually described, may have been a result of 
the long period of time between the index event and 
the performance of IVUS in some cases (mean time 
between index event and IVUS procedure: 7.2 ± 2.1 
days). Thus, it is possible that some ruptured plaques 
scarred, or that the cavity was filled by a thrombus, thus 
hindering their identification through IVUS. Recently, 
calcium nodules, also identifiable by IVUS, were as-
sociated with acute coronary syndrome in 5 to 10% 
of cases.33 The mechanism by which calcium nodules 
result in coronary thrombosis is still unknown. In the 
present cohort, only one patient (4%) had a calcium 
nodule identified by IVUS (Figure 3), similar to the 
prevalence reported in previous studies.
When using tissue characterization through iMAP™, 
the characteristic finding of unstable plaques consists in 
the large amount of necrotic core. In a study by Missel 
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et al.34 using virtual histology, a correlation was found 
between a large necrotic core and reduced calcified 
component, with increased CK-MB release in patients 
with acute coronary syndrome. In this study, the vol-
ume of the necrotic core was found to be 19.2 ± 18.0 
mm3, while the calcified component volume was 1.4 
± 13.9 mm3. Moreover, the authors demonstrated that 
higher-risk patients (those with CK-MB release and ST 
segment depression on ECG) presented high necrotic 
core/dense calcium ratio (NC/DC = 1.83, interquartile 
range, 1.27 to 2.76) as a risk predictor. In the present 
study, which differed from the above mentioned study 
by evaluating patients at higher risk (STEMI) and with 
different tissue characterization technology, a necrotic 
core volume of 60.0 ± 65.6 mm3 and calcified compo-
nent of 6.12 ± 8.34 mm3 were observed, and the NC/
DC ratio was 10.6 ± 13.9. This demonstrates that there 
may be a correlation between a profile of more severe 
patients, represented by STEMI, and a larger number 
of necrotic components in culprit lesions.
In a contemporary study35 comparing patients with 
AMI with or without ST-segment elevation, the mean 
percentage of necrotic component was found to be 37% 
in the STEMI group, while the calcified component was 
only 3%. In the present study, the mean percentage 
of the necrotic component was 23.4 ± 9.2%, and the 
calcified component was 2.17 ± 1.76%. These findings 
are similar when the full extent of the lesion or only the 
MLA are analyzed. In the present analysis, at the point 
of MLA, the mean percentage of necrotic component 
was 23.6 ± 14.8% and the calcified component was 
1.62 ± 1.70%.
Finally, the results demonstrated using iMAP™ in 
patients with STEMI were similar to those previously 
published with VH-IVUS®, demonstrating its potential 
applicability in clinical practice.6-8
Limitations
The present study has several limitations; the main 
ones are related to the low spatial resolution of IVUS, 
especially when compared to OCT. This can result in 
difficulty in the identification and quantification of 
the thrombotic component, which may be mistakenly 
classified as fibrotic component by iMAP™. However, 
unlike the OCT, the IVUS has greater wave penetration, 
allowing for the quantification of arterial remodeling, 
Figure 2 – Intravascular ultrasound cross-sectional images in three different patients, showing examples of ruptured plaque (arrow) as the event that 
triggered the coronary thrombosis.
Figure 3 – Intravascular ultrasound of the right coronary artery show-
ing compatibility with calcium nodule (dense, eruptive mass, with 
irregular surface, in contact with and/or near the lumen, as indicated 
by the arrow).
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for instance. Additionally, the guidewire artifact, while 
interfering minimally in image generation, may have 
been included in this analysis as necrotic component, 
thus overestimating its quantification. The findings of 
the present study are reserved only for patients with 
STEMI after fibrinolytic therapy, thus limiting the external 
validity of the findings.
CONCLUSIONS
In this study, involving a small number of patients 
with STEMI, morphological characterization through 
intravascular ultrasound in grayscale and tissue US 
with iMAP™ technology, showed that there is a pre-
dominance of positive arterial remodeling and necrotic 
component in the composition of the culprit plaque, 
which supports the pathophysiology of atherosclerotic 
disease. The presence of plaque rupture, however, was 
prevalent in only 40% of cases. Future studies using 
new invasive imaging technologies with higher spatial 
resolution are needed to attain a better comprehension 
of the pathophysiology and better treatment promotion 
for patients with acute myocardial infarction with ST-
segment elevation.
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